International trends in COPD mortality, 1995-2017
- PMID: 31744832
- DOI: 10.1183/13993003.01791-2019
International trends in COPD mortality, 1995-2017
Conflict of interest statement
Conflict of interest: J. Lortet-Tieulent has nothing to disclose. Conflict of interest: I. Soerjomataram has nothing to disclose. Conflict of interest: J.L. López-Campos reports personal fees and non-financial support from AstraZeneca, CSL Behring and Ferrer, and grants, personal fees and non-financial support from Boehringer Ingelheim, Chiesi, Esteve, GebroPharma, GlaxoSmithKline, Grifols, Menarini, Novartis, Rovi and Teva, outside the submitted work. Conflict of interest: J. Ancochea has nothing to disclose. Conflict of interest: J.W. Coebergh has nothing to disclose. Conflict of interest: J.B. Soriano participated in speaking activities, advisory committees and consultancies during the period 2014–2019 sponsored by: Almirall, AstraZeneca, Boehringer-Ingelheim, CHEST, Chiesi, ERS, GEBRO, Grifols, GSK, Linde, Lipopharma, Mundipharma, Novartis, Pfizer, RiRL, Rovi, Sandoz, SEPAR and Takeda. J.B. Soriano declares not receiving ever, directly or indirectly, funding from the tobacco industry or its affiliates.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical